Filtros de búsqueda

Lista de obras de

470: Comparison of the Operating Characteristics of PSA for Prostate Cancer Detection for Finasteride and Placebo in the Prostate Cancer Prevention Trial

A Meta-analysis of Individual Participant Data Reveals an Association between Circulating Levels of IGF-I and Prostate Cancer Risk

artículo científico publicado en 2016

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts.

artículo científico publicado en 2017

A functional variant in NKX3.1 associated with prostate cancer risk in the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

artículo científico publicado en 2014

A phase II clinical trial of oral bropirimine in combination with intravesical bacillus Calmette-Guérin for carcinoma in situ of the bladder: a Southwest Oncology Group Study

artículo científico publicado en 2005

A randomized controlled trial of vitamin E and selenium on rate of decline in lung function

artículo científico publicado en 2015

Absolute prostate-specific antigen value after androgen deprivation is a strong independent predictor of survival in new metastatic prostate cancer: data from Southwest Oncology Group Trial 9346 (INT-0162).

artículo científico publicado en 2006

Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial

artículo científico publicado en 2016

Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study

artículo científico publicado en 2020

Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study ⬇️

artículo científico publicado en 2011

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial

artículo científico publicado en 2009

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

artículo científico publicado en 2006

Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer

artículo científico publicado en 2015

African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer

artículo científico publicado en 2020

Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2009

An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection

artículo científico publicado en 2011

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

artículo científico publicado en 2014

Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial

artículo científico publicado en 2010

Antiandrogen withdrawal in castrate-refractory prostate cancer: a Southwest Oncology Group trial (SWOG 9426)

artículo científico publicado en 2008

Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited

artículo científico publicado en 2005

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2006

Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

artículo científico publicado en 2018

Association between variants in genes involved in the immune response and prostate cancer risk in men randomized to the finasteride arm in the Prostate Cancer Prevention Trial

artículo científico publicado en 2017

Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2016

Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916

scientific article published on 17 September 2007

Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial

artículo científico publicado en 2011

Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2017

Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.

artículo científico publicado en 2006

Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride

artículo científico publicado en 2012

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

scholarly article published in Nature Genetics

Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry

scientific article published in Nature Communications

Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk

artículo científico publicado en 2014

Biased hormonal therapy duration analysis makes results uninterpretable

artículo científico publicado en 2009

Biases in Recommendations for and Acceptance of Prostate Biopsy Significantly Affect Assessment of Prostate Cancer Risk Factors: Results From Two Large Randomized Clinical Trials

artículo científico publicado en 2016

Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

artículo científico publicado en 2010

Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride

scientific article published on 11 December 2018

Chemoprevention of prostate cancer

scholarly article by Ian M Thompson et al published August 2009 in Journal of Urology

Choosing phase II endpoints and designs: evaluating the possibilities

artículo científico publicado en 2012

Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial

artículo científico publicado en 2014

Circadian genes and risk of prostate cancer in the prostate cancer prevention trial

artículo científico publicado en 2018

Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses

artículo científico publicado en 2019

Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study

artículo científico publicado en 2018

Circulating adipokine concentrations and risk of five obesity-related cancers: a Mendelian randomization study

artículo científico publicado en 2020

Circulating fatty acids and prostate cancer risk: individual participant meta-analysis of prospective studies

artículo científico publicado en 2014

Circulating microRNAs and treatment response in the Phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer.

artículo científico publicado en 2017

Circulating tumor cell counts are prognostic of overall survival in SWOG S0421: a phase III trial of docetaxel with or without atrasentan for metastatic castration-resistant prostate cancer.

artículo científico publicado en 2014

Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial

artículo científico publicado en 2014

Clinical Outcomes in Men of Diverse Ethnic Backgrounds with Metastatic Castration Resistant Prostate Cancer

artículo científico publicado en 2020

Commentary: the ubiquity of prostate cancer: echoes of the past, implications for the present: "what has been will be again, what has been done will be done again; there is nothing new under the sun." ECCLESIASTES 1:9

Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel

artículo científico publicado en 2020

Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

scientific article published on 19 December 2019

Design and progress of a trial of selenium to prevent prostate cancer among men with high-grade prostatic intraepithelial neoplasia

artículo científico publicado en 2006

Discovery of common and rare genetic risk variants for colorectal cancer

artículo científico publicado en 2018

Do mixed histological features affect survival benefit from neoadjuvant platinum‐based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group‐Directed Intergroup Study (S8710) ⬇️

artículo científico publicado el 24 de noviembre de 2010

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

artículo científico publicado en 2013

Does the level of prostate cancer risk affect cancer prevention with finasteride?

artículo científico publicado en 2008

Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer

artículo científico publicado en 2006

Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial

scientific article published on 01 May 2018

Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade disease

artículo científico publicado en 2015

Erectile dysfunction and subsequent cardiovascular disease

artículo científico publicado en 2005

Erectile function outcome reporting after clinically localized prostate cancer treatment

artículo científico publicado en 2007

Evaluating Intermittent Androgen-Deprivation Therapy Phase III Clinical Trials: The Devil Is in the Details

artículo científico publicado en 2015

Evaluation of Ki67, p53 and angiogenesis in patients enrolled in a randomized study of neoadjuvant chemotherapy with or without cystectomy: a Southwest Oncology Group Study

artículo científico publicado en 2006

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.

artículo científico publicado en 2006

Evaluation of vitamin E and selenium supplementation for the prevention of bladder cancer in SWOG coordinated SELECT.

artículo científico publicado en 2012

Everolimus Exposure as a Predictor of Toxicity in Renal Cell Cancer Patients in the Adjuvant Setting: Results of a Pharmacokinetic Analysis for SWOG S0931 (EVEREST), a Phase III Study (NCT01120249)

scientific article published on 07 August 2019

Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217)

artículo científico publicado en 2014

Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancer

artículo científico publicado en 2008

Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial.

artículo científico publicado en 2007

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2015

Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach

artículo científico publicado en 2008

Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection

artículo científico publicado en 2007

Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatment

artículo científico publicado en 2008

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.

artículo científico publicado en 2018

First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statement

artículo científico publicado en 2004

Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk

scientific article published on 29 July 2020

Germline variation at 8q24 and prostate cancer risk in men of European ancestry

artículo científico publicado en 2018

Guideline for the management of clinically localized prostate cancer: 2007 update.

artículo científico publicado en 2007

Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects

artículo científico publicado en 2020

Impact of previous local treatment for prostate cancer on subsequent metastatic disease

artículo científico publicado en 2002

Implementation of the Prostate Cancer Prevention Trial (PCPT).

artículo científico publicado en 2004

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346).

artículo científico publicado en 2012

Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial

artículo científico publicado en 2012

Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial

artículo científico publicado en 2008

Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial

artículo científico publicado en 2013

Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial.

artículo científico publicado en 2017

Intermittent versus continuous androgen deprivation in prostate cancer

artículo científico publicado en 2013

Intraprostatic inflammation is positively associated with serum PSA in men with PSA <4 ng ml(-1), normal DRE and negative for prostate cancer

artículo científico publicado en 2015

Is there a standard of care for pathologic stage T3 prostate cancer?

artículo científico publicado en 2009

Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111.

artículo científico publicado en 2005

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial

artículo científico publicado en 2016

Long-Term Effects of Finasteride on Prostate Cancer Mortality

artículo científico publicado en 2019

Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial

artículo científico publicado en 2016

Long-term survival of participants in the prostate cancer prevention trial

artículo científico publicado en 2013

Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies

MP69-12 ADDED VALUE OF GENETIC RISK SCORE TO THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR: FINDINGS FROM THE PCPT STUDY

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

Meta-analysis of 16 studies of the association of alcohol with colorectal cancer

artículo científico publicado en 2019

Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioning

artículo científico publicado en 2003

More on Long-Term Effects of Finasteride on Prostate Cancer Mortality. Reply

artículo científico publicado en 2019

Moving a randomized clinical trial into an observational cohort

artículo científico publicado en 2012

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

artículo científico publicado en 2003

Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.

artículo científico publicado en 2002

Opportunities and challenges in incorporating ancillary studies into a cancer prevention randomized clinical trial.

artículo científico publicado en 2016

Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710.

artículo científico publicado en 2014

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel

artículo científico publicado en 2018

Parallel (Randomized) Phase II Evaluation of Tivantinib (ARQ197) and Tivantinib in Combination with Erlotinib in Papillary Renal Cell Carcinoma: SWOG S1107

artículo científico publicado en 2017

Patient-reported outcomes for patients with metastatic castration-resistant prostate cancer receiving docetaxel and Atrasentan versus docetaxel and placebo in a randomized phase III clinical trial (SWOG S0421)

Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer

scientific article published on 01 May 2007

Phase III Intergroup Trial of Adjuvant Androgen Deprivation With or Without Mitoxantrone Plus Prednisone in Patients With High-Risk Prostate Cancer After Radical Prostatectomy: SWOG S9921

artículo científico publicado en 2018

Phase III prostate cancer prevention trials: are the costs justified?

artículo científico publicado en 2005

Phase III trial of selenium to prevent prostate cancer in men with high-grade prostatic intraepithelial neoplasia: SWOG S9917.

artículo científico publicado en 2011

Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis

artículo científico publicado en 2020

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial

artículo científico publicado en 2013

Plasma vitamin D and prostate cancer risk: results from the Selenium and Vitamin E Cancer Prevention Trial

artículo científico publicado en 2014

Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom score

artículo científico publicado en 2013

Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2007

Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949.

artículo científico publicado en 2008

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

artículo científico publicado en 2007

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

artículo científico publicado en 2004

Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894

scientific article published on 01 December 2004

Prostate cancer--uncertainty and a way forward

artículo científico publicado en 2012

Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma

artículo científico publicado en 2010

Prostate-specific antigen: a misused and maligned prostate cancer biomarker

artículo científico publicado en 2008

Publisher Correction: Shared heritability and functional enrichment across six solid cancers

scientific article published on 23 September 2019

Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial

artículo científico publicado en 2008

Re: Long-term survival of participants in the Prostate Cancer Prevention Trial

artículo científico publicado en 2014

Recommended definitions of aggressive prostate cancer for etiologic epidemiologic research

scientific article published on 03 October 2020

Reduced Risk of Prostate Cancer With 5α-Reductase Inhibitors

scientific article published on 01 November 2018

Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2011

Results of the Southwest Oncology Group phase II evaluation (study S0031) of ZD1839 for advanced transitional cell carcinoma of the urothelium

artículo científico publicado en 2009

Retention of black and white participants in the selenium and vitamin E cancer prevention trial (SWOG-coordinated intergroup study S0000).

artículo científico publicado en 2014

S1314 correlative analysis of ATM, RB1, ERCC2, and FANCC mutations and pathologic complete response (pT0) at cystectomy after neoadjuvant chemotherapy (NAC) in patients with muscle invasive bladder cancer (MIBC): Implications for bladder preservatio

artículo científico publicado en 2022

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer

artículo científico publicado en 2015

SWOG S1011: A phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer.

scientific article published in 2023

SWOG S1931 (PROBE): Phase III randomized trial of immune checkpoint inhibitor (ICI) combination regimen with or without cytoreductive nephrectomy (CN) in advanced renal cancer.

artículo científico publicado en 2022

SWOG-9510: evaluation of topotecan in hormone refractory prostate cancer: a Southwest Oncology Group study

artículo científico publicado en 2002

Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study

artículo científico publicado en 2006

Selenium and Prostate Cancer: Analysis of Individual Participant Data From Fifteen Prospective Studies

artículo científico publicado en 2016

Selenium- or Vitamin E-Related Gene Variants, Interaction with Supplementation, and Risk of High-Grade Prostate Cancer in SELECT.

artículo científico publicado en 2016

Serum 25-hydroxyvitamin D concentrations and risk of prostate cancer: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2014

Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2009

Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial

artículo científico publicado en 2015

Serum biomarkers of bone metabolism in castration-resistant prostate cancer patients with skeletal metastases: results from SWOG 0421.

scientific article published on 24 February 2014

Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study

artículo científico publicado en 2011

Shared heritability and functional enrichment across six solid cancers

artículo científico publicado en 2019

Shared heritability and functional enrichment across six solid cancers

Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?

artículo científico publicado en 2013

Sorafenib with interferon alfa-2b as first-line treatment of advanced renal carcinoma: a phase II study of the Southwest Oncology Group

artículo científico

Southwest Oncology Group phase II study of arsenic trioxide in patients with refractory germ cell malignancies.

artículo científico publicado en 2006

Statin drug use is not associated with prostate cancer risk in men who are regularly screened

artículo científico publicado en 2014

Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials

artículo científico publicado en 2004

Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer ⬇️

artículo científico publicado en 2016

Surrogates for Survival or Other End Points in Oncology

artículo científico publicado en 2016

Survival in the prostate cancer prevention trial

artículo científico publicado en 2013

Survival outcomes and risk group validation from SWOG S0925: a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer

artículo científico publicado en 2020

Ten-year follow-up of neoadjuvant therapy with goserelin acetate and flutamide before radical prostatectomy for clinical T3 and T4 prostate cancer: update on Southwest Oncology Group Study 9109.

scientific article published on March 2012

Ten-year survival in patients with metastatic prostate cancer

artículo científico publicado en 2003

The CHEK2 Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor

artículo científico publicado en 2020

The Prostate Cancer Prevention Trial and the future of chemoprevention

artículo científico publicado en 2008

The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcome

artículo científico publicado en 2013

The Prostate Cancer Prevention Trial: design, status, and promise

artículo científico publicado en 2003

The impact of prostate volume, number of biopsy cores and American Urological Association symptom score on the sensitivity of cancer detection using the Prostate Cancer Prevention Trial risk calculator

artículo científico publicado en 2013

The influence of finasteride on the development of prostate cancer

artículo científico publicado en 2003

The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy

artículo científico publicado en 2008

The prognostic impact of seminal vesicle involvement found at prostatectomy and the effects of adjuvant radiation: data from Southwest Oncology Group 8794

artículo científico publicado en 2008

The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894

scientific article published on 01 August 2006

The prostate cancer prevention trial: design, biases and interpretation of study results

artículo científico publicado en 2006

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials

article

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

artículo científico publicado en 2021

Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.

artículo científico publicado en 2010

Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.

artículo científico publicado en 2008

Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial

artículo científico publicado en 2020

Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial.

artículo científico publicado en 2018

Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421.

artículo científico publicado en 2017

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

artículo científico publicado en 2015

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in

artículo científico publicado en 2007

Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMI

scientific article published on 19 October 2019

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

artículo científico publicado en 2020

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda